When morphology is equivocal, immunohistochemistry can assist: aberrant p16 and p53 with a diffuse Ki‐67 pattern favor cSCC, whereas keratoacanthoma more often shows a peripheral, graded Ki‐67 pattern [5]. The gene discussed is MKI67; the disease is skin squamous cell carcinoma.